Global Markets React to Tariffs, AI, Drug Trials, and Fed Uncertainty
Analysis based on 16 articles · First reported Feb 23, 2026 · Last updated Feb 24, 2026
Global markets are experiencing mixed sentiments due to various factors including Donald Trump's new tariffs, concerns over AI competition impacting companies like CrowdStrike and AppLovin, and a significant drug trial result affecting Novo Nordisk and Eli Lilly and Company. The United States===Federal Reserve's potential interest rate decision also adds to market uncertainty.
Asian shares were mixed following a slump in U.S. stocks. This was driven by heavy selling in companies perceived as potential losers in the artificial-intelligence boom, such as CrowdStrike and AppLovin. Donald Trump's announcement of new temporary 15% tariffs, after a United States===Supreme Court of the United States ruling against his previous 'reciprocal' taxes, also contributed to market uncertainty. Airline stocks like United Airlines, American Airlines, and Delta Air Lines fell due to flight cancellations from severe weather. In the pharmaceutical sector, Novo Nordisk's stock tumbled after its CagriSema drug trial showed less weight loss than a rival drug from Eli Lilly and Company, which saw its stock rise. United States===Federal Reserve Governor Christopher Waller indicated uncertainty regarding a March interest rate cut. Oil prices gained on geopolitical worries concerning Donald Trump and Iran, while the United States===United States dollar strengthened against the Japan===Japanese yen and euro, and Bitcoin declined.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard